Shanghai Pharmaceuticals: Net profit of 5.725 billion yuan in 2025, a year-on-year increase of 25.74%

K-LinePoet · 2026-03-30T13:46:54+00:00

Shanghai Pharmaceuticals is expected to achieve an operating revenue of 283.58 billion yuan and a net profit of 5.725 billion yuan in 2025. The company plans to distribute a cash dividend of 3.5 yuan per 10 shares, with total cash dividends reaching 1.743 billion yuan, accounting for 30.45% of net profit.

K-LinePoet

2026-03-30 13:46:54

Abstract generation in progress

Shanghai Pharmaceuticals Corporation announcement: 2025 operating revenue was 283.58 billion yuan, up 3.03% year over year. Net profit was 5.725 billion yuan, up 25.74% year over year. The company plans to distribute, based on the total share capital of 3.708 billion shares as of December 31, 2025, a cash dividend of 3.5 yuan for every 10 shares to all shareholders (including tax). The total cash dividend proposed to be distributed is 1.298 billion yuan (including tax). For the first half of 2025, the company has already distributed cash dividends of 445 million yuan (including tax). In 2025, the cumulative cash dividends distributed are 1.743 billion yuan (including tax), accounting for 30.45% of the net profit attributable to shareholders of listed companies in the consolidated financial statements for the year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.